AHA Statement on Potential New Payment Model for Part B Drugs



Rick Pollack

AHA President and CEO

October 25, 2018



America’s hospitals and health systems are pleased that President Trump and his administration are focused on reining in out-of-control drug prices, which continue to threaten patient access and the ability of providers to deliver the highest quality of care. We look forward to reviewing the details of the model closely, including its impact on 340B hospitals and the patients they serve.


About the American Hospital Association

The AHA is a not-for-profit association of health care provider organizations and individuals that are committed to the improvement of health in their communities. The AHA is the national advocate for its members, which include nearly 5,000 hospitals, health care systems, networks and other providers of care. Founded in 1898, the AHA provides education for health care leaders and is a source of information on health care issues and trends. For more information, visit https://www.aha.org.




Marie Johnson, (202) 626-2351

Colin Milligan, (202) 638-5491




Related Resources

Special Bulletin
Special Bulletin on CMS’s Nov. 26 proposed rule aimed at lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.
The AHA urges the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and…
Special Bulletin
On October 25, the Centers for Medicare…
AHA Center for Health Innovation Market Scan
For the second time in less than a month, the Department of Justice has approved a megamerger between leading players in the health insurance and pharmacy…
AHA letter to the US Senate supporting Amendment #3787 to address ‘out-of-control cost’ of prescription drugs.